Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2008
The use of tapered self-expanding stents and embolic protection devices in the treatment of stenotic ectatic coronary arteries: a report of two cases.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Le Vu, Abu-Fadel Mazen, Hennebry Thomas A
Аннотация
OBJECTIVE: The usage of tapered self-expanding stents and embolic protection devices in the treatment of stenotic ectatic coronary arteries.
BACKGROUND: Coronary artery ectasia (CAE) is an uncommon disease that is occasionally found during cardiac catheterization. A high incidence of artherosclerotic disease is associated with CAE. Currently, there is no evidence-based approach for the management of stenotic ectatic coronary arteries (SEC).
METHODS: Percutaneous intervention with carotid stenting system and embolic protection system to recanalize SEC.
RESULTS: We describe two patients who presented with acute coronary syndrome and were found to have CAE with significant stenosis. Both patients underwent percutaneous intervention with RX ACCULINK Carotid stenting system and ACCUNET embolic protection system (Abbott Laboratories, Abbott Park, IL), successfully. This carotid stenting system is approved by FDA for stenting of extracranial carotid artery stenosis.
CONCLUSION: To the best of our knowledge, this is the first case report illustrating the usage of these devices as an alternative for the treatment of SEC.
BACKGROUND: Coronary artery ectasia (CAE) is an uncommon disease that is occasionally found during cardiac catheterization. A high incidence of artherosclerotic disease is associated with CAE. Currently, there is no evidence-based approach for the management of stenotic ectatic coronary arteries (SEC).
METHODS: Percutaneous intervention with carotid stenting system and embolic protection system to recanalize SEC.
RESULTS: We describe two patients who presented with acute coronary syndrome and were found to have CAE with significant stenosis. Both patients underwent percutaneous intervention with RX ACCULINK Carotid stenting system and ACCUNET embolic protection system (Abbott Laboratories, Abbott Park, IL), successfully. This carotid stenting system is approved by FDA for stenting of extracranial carotid artery stenosis.
CONCLUSION: To the best of our knowledge, this is the first case report illustrating the usage of these devices as an alternative for the treatment of SEC.